Susan E. Knight - 19 Nov 2025 Form 4 Insider Report for SURMODICS INC (SRDX)

Reporting relationship: Director
Issuer ticker: SRDX
Reported as of: 19 Nov 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Nov 2025, 18:10:05 UTC
Prior SEC filing: 28 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ John Manders on behalf of Susan E. Knight

Key filing fact

Susan E. Knight filed Form 4 for SURMODICS INC (SRDX) on 19 Nov 2025.

Key facts

This page summarizes Susan E. Knight's Form 4 filing for SURMODICS INC (SRDX).
7 reported transactions and 6 derivative rows are listed below.
Accepted by SEC: 19 Nov 2025, 18:10.

Change

Previous filing in this sequence was filed on 28 Jan 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001183157 Primary reporting owner

KNIGHT SUSAN E

Relationship: Director
Address: 9154 BRECKENRIDGE LANE, EDEN PRAIRIE
Signature: /s/ John Manders on behalf of Susan E. Knight
Signature date: 19 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRDX transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -37,240
Change %: -100%
Price
Shares after: 0
Date: 19 Nov 2025
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SRDX transaction Derivative

Employee Stock Option (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -3,634
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 19 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,634
Exercise price: $55.24
Footnotes: F3

SRDX transaction Derivative

Employee Stock Option (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -4,548
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 19 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,548
Exercise price: $39.58
Footnotes: F3

SRDX transaction Derivative

Employee Stock Options (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -3,196
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 19 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,196
Exercise price: $53.86
Footnotes: F3

SRDX transaction Derivative

Employee Stock Option (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -3,555
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 19 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,555
Exercise price: $41.81
Footnotes: F3

SRDX transaction Derivative

Employee Stock Option (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -5,040
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 19 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,040
Exercise price: $28.98
Footnotes: F3

SRDX transaction Derivative

Employee Stock Option (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -4,155
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 19 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,155
Exercise price: $31.89
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Susan E. Knight is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 3 footnotes

Footnote F1

Pursuant to that certain Merger Agreement, dated as of May 28, 2024, by and among the Surmodics, Inc. (the "Issuer"), BCE Parent, LLC, ("Parent"), and BCE Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.05 per share ("Common Stock"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $43.00 per share in cash, without interest and subject to any applicable tax withholdings (the "Merger Consideration"). All outstanding restricted stock units ("RSUs") held by the reporting person vested immediately prior to the Effective Time and the reporting person is entitled to receive the Merger Consideration for such vested RSUs.

Footnote F2

As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Common Stock.

Footnote F3

Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option ("Option") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings.